Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lufax Holding Ltd (LU) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance

Lufax Holding LtdTrade
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade

Price performance (Past 24H)

Key statistics

Lufax Holding Ltd vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Lufax Holding Ltd trades at $0.85 (market cap $894.58M), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.57B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 71.1× Lufax Holding Ltd's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.49% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals.

LURELX
Market Cap
$894.58M$63.57B
Volume
1,044,9761,602,093
Sector
FinancialsIndustrials
52-Week High
$3.64$46.80
52-Week Low
$0.86$27.73
Typical Hold Time
14 Days—
Enterprise Value
$58.66B$75.05B
Dividend Yield
—2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lufax Holding Ltd

Lufax Holding Ltd (LU) trades at $0.9201, down 0.47% on the day, reflecting ongoing challenges in China's consumer lending market. The stock shows a bearish technical signal with negative earnings trends, having missed EPS estimates for three consecutive quarters. Recent corporate actions include a 10:1 reverse stock split effective October 2026. Despite deep value metrics (P/S 0.24, P/B 0.07), the company reports negative net income margins and declining revenue, with 2025 showing a $2.10B loss on $23.11B revenue.

LU presents a high-risk opportunity with significant analyst divergence. While 69% of analysts rate it Buy citing deep valuation and Ping An backing, fundamental deterioration and regulatory headwinds create substantial downside risk. The stock's appeal rests on potential capital return catalysts rather than business turnaround, requiring careful risk assessment given China's tightening financial regulations and persistent operational losses.

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LU
2% Buy98% Sell
Avg holding period · 14 Days
RELX

No sentiment data available yet.

About Lufax Holding Ltd

Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.

Read more on LU →

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →